Vir Biotechnology Shares Outstanding 2018-2021 | VIR

Vir Biotechnology shares outstanding history from 2018 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Vir Biotechnology shares outstanding for the quarter ending June 30, 2021 were 0.134B, a 16.36% increase year-over-year.
  • Vir Biotechnology 2020 shares outstanding were 0.119B, a 292.62% increase from 2019.
  • Vir Biotechnology 2019 shares outstanding were 0.03B, a 295.9% increase from 2018.
  • Vir Biotechnology 2018 shares outstanding were 0.008B, a 256.23% increase from 2017.
Vir Biotechnology Annual Shares Outstanding
(Millions of Shares)
2020 119
2019 30
2018 8
2017 2
Vir Biotechnology Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 134
2021-03-31 128
2020-12-31 119
2020-09-30 126
2020-06-30 115
2020-03-31 108
2019-12-31 30
2019-09-30 11
2019-06-30 9
2019-03-31 9
2018-12-31
2018-09-30 8
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.837B $0.076B
Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71